Hypogammaglobulinemia
·MeSH: Agammaglobulinemia
Prevalence
5.0 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| xembify | Grifols S.A. (GRFS) |
Frequently asked questions
How many drugs are in development for Hypogammaglobulinemia?
BioSniper tracks 1 drug in development for Hypogammaglobulinemia across 1 company.
How many clinical trials target Hypogammaglobulinemia?
There are 1 clinical trial targeting Hypogammaglobulinemia tracked by BioSniper.
What is the prevalence of Hypogammaglobulinemia?
The estimated prevalence of Hypogammaglobulinemia is approximately 5.0 per 100,000 population.
Deep-dive into Hypogammaglobulinemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis